Trulieve Cannabis (OTCMKTS:TCNNF – Get Free Report) is anticipated to issue its results before the market opens on Friday, August 7th. Analysts expect Trulieve Cannabis to announce earnings of $0.06 per share and revenue of $284.0840 million for the quarter.
Trulieve Cannabis Price Performance
Shares of OTCMKTS:TCNNF opened at $11.86 on Thursday. The company’s fifty day moving average is $11.48 and its two-hundred day moving average is $8.65. Trulieve Cannabis has a 12-month low of $3.25 and a 12-month high of $13.28.
Analyst Ratings Changes
Separately, Alliance Global Partners reaffirmed a “buy” rating on shares of Trulieve Cannabis in a research report on Thursday, June 4th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, Trulieve Cannabis currently has an average rating of “Buy”.
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis operator and retailer, offering a full suite of services from cultivation and processing to distribution and sales. The company develops, manufactures and markets a diverse range of cannabis products under its own brand portfolio, serving both medical and adult-use consumers through a network of branded dispensaries and delivery services.
Trulieve’s product lineup includes dried flower, vape cartridges, concentrates, edibles, tinctures and topicals, all of which are produced in compliance with state regulatory requirements.
Featured Stories
- Five stocks we like better than Trulieve Cannabis
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
